Guidance for U.S. Laboratories for Managing and Testing Routine Clinical Specimens When There is a Concern About Ebola Virus Disease

Centers for Disease Control and Prevention. (2015). Guidance for U.S. Laboratories for Managing and Testing Routine Clinical Specimens When There is a Concern About Ebola Virus Disease.
This guidance is geared toward clinicians who are responsible for managing and testing clinical specimens for Ebola. Guidance covers the use of personal protective equipment, laboratory equipment, patient transport, decontamination, and other related topics.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.